Vakaramoko Diaby to Health Care Costs
This is a "connection" page, showing publications Vakaramoko Diaby has written about Health Care Costs.
Connection Strength
0.608
-
Tran PT, Nduaguba SO, Wang Y, Diaby V, Finelli L, Choi Y, Winterstein AG. Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5?Years of Age in the USA. Influenza Other Respir Viruses. 2024 Jul; 18(7):e13347.
Score: 0.233
-
Jiang X, Vouri SM, Diaby V, Lo-Ciganic W, Parker R, Park H. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C. J Manag Care Spec Pharm. 2021 Oct; 27(10):1388-1402.
Score: 0.192
-
Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):187-196.
Score: 0.136
-
van Boemmel-Wegmann S, Brown JD, Diaby V, Huo J, Silver N, Park H. Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States. JCO Oncol Pract. 2022 01; 18(1):e163-e174.
Score: 0.047